Full Text View
Tabular View
No Study Results Posted
Related Studies
Eltrombopag for the Prevention of Chemotherapy Induced Thrombocytopenia
This study has been terminated.
( Unable to accrue subjects to the study. )
Study NCT01491594   Information provided by Duke University

First Received on December 12, 2011.   Last Updated on April 11, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Sarcoma, Soft Tissue
Osteosarcoma
Additional conditions recognized in this trial
Neoplasms
Neoplasms, Connective and Soft Tissue
Sarcoma
Thrombocytopenia
More general conditions related to this trial
Blood Platelet Disorders
Hematologic Diseases
Neoplasms by Histologic Type
Neoplasms, Bone Tissue
Neoplasms, Connective Tissue
Interventions listed in this trial
Eltrombopag
Sponsors listed in this trial
Duke University
GlaxoSmithKline


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services